1 / 18

Efficacy and safety of lersivirine vs efavirenz in antiretroviral treatment-na ve HIV-1-infected patients: Week 48 pri

2. Lersivirine: a next-generation NNRTI with unique binding and potent activity against HIV-1. Binds to the reverse transcriptase (RT) enzyme in a novel way1Unique resistance profile2 Antiretroviral (ARV) activity2IC50 = 5.83 nM; 1.81 ng/mL (PBC)Resistance generated in vitro2V108I pathway to re

erma
Télécharger la présentation

Efficacy and safety of lersivirine vs efavirenz in antiretroviral treatment-na ve HIV-1-infected patients: Week 48 pri

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related